David Harrich
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
Papers in
- Virology 58
- HIV Research and Treatment 58
-
- HIV/AIDS drug development and treatment 31
- Viral Infections and Vectors 6
- Co-authors
- Richard B. Gaynor (18 shared papers)F Wu (6 shared papers)Haran Sivakumaran (19 shared papers)Ronald T. Mitsuyasu (4 shared papers)Joseph A. Garcia (8 shared papers)León F. Garcı́a-Martı́nez (1 shared paper)S.-H.I. Ou (1 shared paper)David A. Jans (4 shared papers)
- Journals
- Journal of Virology (19 papers)The EMBO Journal (7 papers)Virology Journal (6 papers)PLoS ONE (4 papers)Retrovirology (3 papers)
- Partner nations
- AustraliaUnited StatesChina
In The Last Decade
David Harrich
87 papers receiving 4.4k citations
David Harrich's Hit Papers
Peers
Comparison fields: 5 of 129
- Virology 1.9k
- Infectious Diseases 1.4k
- Immunology 868
- Neurology 528
- Molecular Biology 2.0k
Countries citing papers authored by David Harrich
This map shows the geographic impact of David Harrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Harrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Harrich more than expected).
Fields of papers citing papers by David Harrich
This network shows the impact of papers produced by David Harrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Harrich. The network helps show where David Harrich may publish in the future.
Co-authors
The 25 scholars most cited alongside David Harrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs Hit paper breakdown → | 1995 | 607 |
| 2 | Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus Hit paper breakdown → | 2012 | 523 |
| 3 | 1989 | 248 | |
| 4 | 1995 | 204 | |
| 5 | 1988 | 187 | |
| 6 | 1988 | 171 | |
| 7 | 1989 | 159 | |
| 8 | 1996 | 131 | |
| 9 | 1997 | 130 | |
| 10 | 1990 | 107 | |
| 11 | 2013 | 102 | |
| 12 | 2002 | 71 | |
| 13 | 2020 | 71 | |
| 14 | 2003 | 63 | |
| 15 | 2023 | 58 | |
| 16 | 2006 | 52 | |
| 17 | 1988 | 52 | |
| 18 | 2009 | 51 | |
| 19 | 1996 | 51 | |
| 20 | 2000 | 51 |
About David Harrich
David Harrich is a scholar working on Virology, Infectious Diseases, Molecular Biology, Epidemiology and Genetics, having authored 87 papers that have together received 4.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (58 papers), HIV/AIDS drug development and treatment (31 papers), Virus-based gene therapy research (11 papers), RNA Research and Splicing (11 papers), Immune Cell Function and Interaction (9 papers), RNA Interference and Gene Delivery (9 papers), RNA and protein synthesis mechanisms (7 papers) and Viral Infections and Vectors (6 papers). The work is most often cited by research in Virology (1.9k citations), Infectious Diseases (1.4k citations), Immunology (868 citations), Neurology (528 citations) and Molecular Biology (2.0k citations). David Harrich has collaborated with scholars based in Australia, United States and China. Frequent co-authors include Richard B. Gaynor, F Wu, Haran Sivakumaran, Ronald T. Mitsuyasu, Joseph A. Garcia, León F. Garcı́a-Martı́nez, S.-H.I. Ou, David A. Jans, Kylie M. Wagstaff and Steven M. Heaton. Their work appears in journals such as Journal of Virology, The EMBO Journal, Virology Journal, PLoS ONE and Retrovirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.